BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8698456)

  • 1. Conservation of the C5a peptidase genes in group A and B streptococci.
    Chmouryguina I; Suvorov A; Ferrieri P; Cleary PP
    Infect Immun; 1996 Jul; 64(7):2387-90. PubMed ID: 8698456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity between the group B and A streptococcal C5a peptidase genes.
    Cleary PP; Handley J; Suvorov AN; Podbielski A; Ferrieri P
    Infect Immun; 1992 Oct; 60(10):4239-44. PubMed ID: 1398935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a.
    Bohnsack JF; Takahashi S; Hammitt L; Miller DV; Aly AA; Adderson EE
    Infect Immun; 2000 Sep; 68(9):5018-25. PubMed ID: 10948119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes.
    Chen CC; Cleary PP
    J Biol Chem; 1990 Feb; 265(6):3161-7. PubMed ID: 2406246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional similarity of C5a-ase enzymes from group A and B streptococci.
    Chmouryguina II; Suvorov AN; Carlson B; Cleary P
    Adv Exp Med Biol; 1997; 418():757-9. PubMed ID: 9331762
    [No Abstract]   [Full Text] [Related]  

  • 6. VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci.
    Chen C; Bormann N; Cleary PP
    Mol Gen Genet; 1993 Dec; 241(5-6):685-93. PubMed ID: 7505389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.
    Ji Y; McLandsborough L; Kondagunta A; Cleary PP
    Infect Immun; 1996 Feb; 64(2):503-10. PubMed ID: 8550199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity.
    Tamura GS; Hull JR; Oberg MD; Castner DG
    Infect Immun; 2006 Oct; 74(10):5739-46. PubMed ID: 16988251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.
    Beckmann C; Waggoner JD; Harris TO; Tamura GS; Rubens CE
    Infect Immun; 2002 Jun; 70(6):2869-76. PubMed ID: 12010974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.
    Podbielski A; Flosdorff A; Weber-Heynemann J
    Infect Immun; 1995 Jan; 63(1):9-20. PubMed ID: 7806389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1.7 Å crystal structure of the C5a peptidase from Streptococcus agalactiae (ScpB) reveals an active site competent for catalysis.
    Cullen R; Teçza M; Miclot T; Behan S; Jain M; Avink MK; Cooney JC; Kagawa TF
    Proteins; 2024 Mar; 92(3):427-431. PubMed ID: 37921533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human serum induces streptococcal c5a peptidase expression.
    Gleich-Theurer U; Aymanns S; Haas G; Mauerer S; Vogt J; Spellerberg B
    Infect Immun; 2009 Sep; 77(9):3817-25. PubMed ID: 19506013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnosis of group B streptococci by scpB gene based PCR.
    Dmitriev A; Suvorov A; Shen AD; Yang YH
    Indian J Med Res; 2004 May; 119 Suppl():233-6. PubMed ID: 15232202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitous occurrence of virR and scpA genes in group A streptococci.
    Podbielski A
    Med Microbiol Immunol; 1992; 181(4):227-40. PubMed ID: 1435518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate.
    Stafslien DK; Cleary PP
    J Bacteriol; 2000 Jun; 182(11):3254-8. PubMed ID: 10809707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus.
    McIver KS; Heath AS; Green BD; Scott JR
    J Bacteriol; 1995 Nov; 177(22):6619-24. PubMed ID: 7592441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination.
    Pritchard KH; Cleary PP
    Mol Gen Genet; 1996 Feb; 250(2):207-13. PubMed ID: 8628220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis.
    Granlund M; Oberg L; Sellin M; Norgren M
    J Infect Dis; 1998 Apr; 177(4):967-76. PubMed ID: 9534970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcal C5a peptidase is a highly specific endopeptidase.
    Cleary PP; Prahbu U; Dale JB; Wexler DE; Handley J
    Infect Immun; 1992 Dec; 60(12):5219-23. PubMed ID: 1452354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
    Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC
    J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.